Penicillin allergy delabeling: Opportunities for implementation and dissemination
- PMID: 36563744
- PMCID: PMC11949300
- DOI: 10.1016/j.anai.2022.12.023
Penicillin allergy delabeling: Opportunities for implementation and dissemination
Abstract
Although existing as a safety measure to prevent iatrogenic harm, unconfirmed penicillin allergy labels have a negative impact on personal and public health. One downstream effect of unconfirmed penicillin allergy is the continued emergence and transmission of resistant bacteria and their associated health care costs. Recognizing the consequences of inaccurate penicillin allergy labels, professional and public health organizations have started promoting the adoption of proactive penicillin allergy evaluations, with the ultimate goal of removing the penicillin allergy label when the allergy is disproved, also known as penicillin allergy "delabeling." A penicillin allergy evaluation includes a comprehensive allergy history often followed by drug challenge, sometimes with preceding skin testing. Currently, penicillin allergy delabeling is largely carried out by allergy specialists in outpatient settings. Penicillin allergy delabeling is performed on inpatients, albeit rarely, often at the time of need, as a point-of-care procedure. Access to penicillin allergy evaluation services is limited. Recent studies demonstrate the feasibility of expanding penicillin allergy evaluations and delabeling to internists, pediatricians, emergency medicine physicians, infectious diseases specialists, and clinical pharmacists. However, reducing the impact of mislabeled penicillin allergy will require comprehensive efforts and new investments. In this review, we summarize the current practices of penicillin allergy delabeling and discuss expansion opportunities for penicillin allergy delabeling as quality improvement.
Copyright © 2022 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Figures




Similar articles
-
Nonallergist Delabeling-Should Penicillin Allergy Delabeling Only Be Performed by Allergists?J Allergy Clin Immunol Pract. 2025 May;13(5):1011-1017.e2. doi: 10.1016/j.jaip.2024.11.028. Epub 2024 Dec 24. J Allergy Clin Immunol Pract. 2025. PMID: 39725315 Review.
-
Penicillin Allergy Delabeling: A Multidisciplinary Opportunity.J Allergy Clin Immunol Pract. 2020 Oct;8(9):2858-2868.e16. doi: 10.1016/j.jaip.2020.04.059. J Allergy Clin Immunol Pract. 2020. PMID: 33039010 Free PMC article. Review.
-
Delabeling of Penicillin Allergy: Room for Improvement.Int Arch Allergy Immunol. 2023;184(9):870-874. doi: 10.1159/000530770. Epub 2023 Jun 15. Int Arch Allergy Immunol. 2023. PMID: 37321191
-
Comparative Effectiveness, Safety, and Real-World Outcomes of a Nurse-Led, Protocol-Driven Penicillin Allergy Evaluation From the Hong Kong Drug Allergy Delabelling Initiative (HK-DADI).J Allergy Clin Immunol Pract. 2023 Feb;11(2):474-480.e2. doi: 10.1016/j.jaip.2022.08.052. Epub 2022 Sep 17. J Allergy Clin Immunol Pract. 2023. PMID: 36126867
-
Protocol for a systematic review and meta-analysis of interventions aimed at delabeling low-risk penicillin allergies with consideration for sex and gender.Syst Rev. 2024 Oct 14;13(1):259. doi: 10.1186/s13643-024-02671-5. Syst Rev. 2024. PMID: 39402648 Free PMC article.
Cited by
-
Long-Term Outcomes Associated With β-Lactam Allergies.JAMA Netw Open. 2024 May 1;7(5):e2412313. doi: 10.1001/jamanetworkopen.2024.12313. JAMA Netw Open. 2024. PMID: 38758551 Free PMC article.
-
Leveraging implementation science theories to develop and expand the use of a penicillin allergy de-labeling intervention.BMC Health Serv Res. 2024 Aug 26;24(1):987. doi: 10.1186/s12913-024-11364-7. BMC Health Serv Res. 2024. PMID: 39187854 Free PMC article.
-
Narrative review of recent developments and the future of penicillin allergy de-labelling by non-allergists.NPJ Antimicrob Resist. 2024 Jul 10;2(1):18. doi: 10.1038/s44259-024-00035-6. NPJ Antimicrob Resist. 2024. PMID: 39843524 Free PMC article. Review.
-
Barriers to penicillin allergy de-labeling in the inpatient and outpatient settings: a qualitative study.Allergy Asthma Clin Immunol. 2023 Oct 11;19(1):88. doi: 10.1186/s13223-023-00842-y. Allergy Asthma Clin Immunol. 2023. PMID: 37821953 Free PMC article.
-
Proactive Deep Learning-Facilitated Inpatient Penicillin Allergy Delabelling: An Implementation Study.Int Arch Allergy Immunol. 2025;186(8):716-723. doi: 10.1159/000542589. Epub 2025 Jan 17. Int Arch Allergy Immunol. 2025. PMID: 39827874 Free PMC article.
References
-
- Castells M, Khan DA, Phillips EJ. Penicillin allergy. N Engl J Med. 2019;381(24):2338–2351. - PubMed
-
- Macy E, Poon KYT. Self-reported antibiotic allergy incidence and prevalence: age and sex effects. Am J Med. 2009;122(8). 778.e1–778.e7. - PubMed
-
- Wurcel AG, Guardado R, Ortiz C, Bornmann CR, Gillis J, Huang K, et al. Low frequency of allergy referral for penicillin allergy evaluation in an urban Boston primary care setting. J Allergy Clin Immunol Glob. 2022. https://www.jaci-global.org/article/S2772-8293(22)00083-2/fulltext. Accessed January 6, 2023. - PMC - PubMed
-
- Hampton LL, DeBoy JT, Hornik CP, White MJ, Nazareth-Pidgeon KM. Association of sociodemographic factors with reported penicillin allergy in pediatric inpatients. Hosp Pediatr. 2022;12(7):625–631. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical